1. Home
  2. ICCC vs FMY Comparison

ICCC vs FMY Comparison

Compare ICCC & FMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmuCell Corporation

ICCC

ImmuCell Corporation

N/A

Current Price

$6.54

Market Cap

55.5M

Sector

Health Care

ML Signal

N/A

Logo First Trust Motgage Income Fund of Beneficial Interest

FMY

First Trust Motgage Income Fund of Beneficial Interest

N/A

Current Price

$11.72

Market Cap

51.7M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ICCC
FMY
Founded
1982
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
55.5M
51.7M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ICCC
FMY
Price
$6.54
$11.72
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
12.1K
4.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
6.98%
EPS Growth
65.33
N/A
EPS
0.20
N/A
Revenue
$26,493,169.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$32.15
N/A
Revenue Growth
51.64
N/A
52 Week Low
$4.32
$11.65
52 Week High
$7.60
$12.39

Technical Indicators

Market Signals
Indicator
ICCC
FMY
Relative Strength Index (RSI) 53.29 33.05
Support Level $6.13 N/A
Resistance Level $6.87 $12.34
Average True Range (ATR) 0.24 0.10
MACD -0.01 -0.05
Stochastic Oscillator 68.57 4.62

Price Performance

Historical Comparison
ICCC
FMY

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About FMY First Trust Motgage Income Fund of Beneficial Interest

First Trust Mortgage Income Fund is a United States-based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income. Its secondary investment objective is to preserve capital. The fund pursues its objectives by investing predominantly in mortgage-backed securities representing part ownership in a pool of either residential or commercial mortgage loans that, in the opinion of the Fund's investment advisor, offer an attractive combination of credit quality, yield, and maturity.

Share on Social Networks: